Hyperliquid Strategies completes business combination with Sonnet BioTherapeutics Dec 2, 2025 04:31PM
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination Dec 2, 2025 04:30PM
Sonnet BioTherapeutics agrees to $888 million crypto treasury deal Jul 14, 2025 06:00AM
Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy Jul 14, 2025 06:00AM
Sonnet BioTherapeutics (SONN) Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules Dec 9, 2024 03:43PM


Dec 9, 2024 03:42PM Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Nov 6, 2024 01:20PM Sonnet BioTherapeutics (SONN) Prices 1.11M Share Offering at $4.50/sh
Nov 6, 2024 01:20PM Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
Aug 14, 2024 08:35AM Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
May 22, 2024 08:35AM Sonnet BioTherapeutics (SONN) Announces Review of Strategic Alternatives
May 22, 2024 07:00AM Sonnet BioTherapeutics Announces Review of Strategic Alternatives
May 14, 2024 04:15PM Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnings Update
Oct 25, 2023 07:32AM Sonnet BioTherapeutics (SONN) Announces Pricing of $4.55 Million Underwritten Public Offering
Oct 25, 2023 07:30AM Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
Jun 28, 2023 08:03AM Sonnet BioTherapeutics (SONN) Prices 5M Share Offering at $0.45/sh
Jun 28, 2023 08:00AM Sonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement
Feb 8, 2023 08:07AM Sonnet BioTherapeutics (SONN) Prices $15M Offering of Common Stock, Warrants
Feb 8, 2023 08:00AM Sonnet BioTherapeutics Announces Pricing of $15.0 Million Underwritten Public Offering
Dec 20, 2021 07:29AM Sonnet BioTherapeutics (SONN) PT Lowered to $2.50 at Chardan Capital Markets
Aug 20, 2021 05:38AM Sonnet BioTherapeutics (SONN) Prices 35.3M Share+Warrant Offering at $0.85/sh
Aug 19, 2021 09:35PM Sonnet BioTherapeutics Announces Pricing of $30 Million Underwritten Public Offering
Aug 4, 2020 07:37AM Sonnet BioTherapeutics (SONN) Announces At-The-Market Warrant Repricing and Exchange Resulting in Expected Gross Proceeds to the Company of up to $10.5 Million
Aug 4, 2020 07:35AM Sonnet BioTherapeutics Announces At-The-Market Warrant Repricing and Exchange Resulting in Expected Gross Proceeds to the Company of up to $10.5 Million
Jun 5, 2020 07:44AM Chardan Capital Markets Starts Sonnet BioTherapeutics (SONN) at Buy